Extension Study to Evaluate the Safety and Clinical Benefit of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Condition:   Cushing Syndrome Intervention:   Drug: relacorilant Sponsor:   Corcept Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2018 Category: Research Source Type: clinical trials